Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Operating Expenses: 2015-2025

Historic Operating Expenses for Editas Medicine (EDIT) over the last 11 years, with Sep 2025 value amounting to $32.1 million.

  • Editas Medicine's Operating Expenses fell 51.18% to $32.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.2 million, marking a year-over-year decrease of 15.52%. This contributed to the annual value of $283.5 million for FY2024, which is 14.62% up from last year.
  • Editas Medicine's Operating Expenses amounted to $32.1 million in Q3 2025, which was down 41.78% from $55.1 million recorded in Q2 2025.
  • Editas Medicine's Operating Expenses' 5-year high stood at $84.0 million during Q4 2023, with a 5-year trough of $32.1 million in Q3 2025.
  • Moreover, its 3-year median value for Operating Expenses was $65.7 million (2024), whereas its average is $63.5 million.
  • Per our database at Business Quant, Editas Medicine's Operating Expenses spiked by 54.14% in 2024 and then plummeted by 51.18% in 2025.
  • Quarterly analysis of 5 years shows Editas Medicine's Operating Expenses stood at $54.1 million in 2021, then increased by 29.41% to $70.0 million in 2022, then rose by 20.05% to $84.0 million in 2023, then declined by 8.11% to $77.2 million in 2024, then crashed by 51.18% to $32.1 million in 2025.
  • Its Operating Expenses was $32.1 million in Q3 2025, compared to $55.1 million in Q2 2025 and $80.8 million in Q1 2025.